Exchange Listed Funds Trust has released its latest financial report, detailing the status of its Bancreek U.S. Large Cap ETF. The report, filed on October 29, 2026, indicates that the fund has total assets of approximately $152.8 million, with liabilities amounting to about $92,725.76, resulting in net assets of around $152.7 million. This update is significant as it highlights the fund's management and performance in a competitive investment landscape.
Background
Exchange Listed Funds Trust, incorporated in Delaware, operates as an investment entity. The firm primarily focuses on managing exchange-traded funds (ETFs), with its notable product being the Bancreek U.S. Large Cap ETF. The company has been active in the regulatory space, with recent filings including multiple NPORT-P forms on October 29, 2026, demonstrating its commitment to transparency and compliance.
What the Filing Says
The recent filing, accession number 0000910472-26-016528, provides a snapshot of the fund's financial health as of August 31, 2026. It states, "Total assets are reported at $152,821,260.94, while total liabilities are $92,725.76, leading to net assets of $152,728,535.18." This information is crucial for investors and stakeholders monitoring the fund's performance.
Impact
The financial update may affect a variety of stakeholders, including current investors in the Bancreek U.S. Large Cap ETF and potential investors looking to enter the market. Additionally, the report serves as a benchmark for competitors in the investment industry, as they assess their own performance relative to Exchange Listed Funds Trust.
What's Next
The filing does not say what happens next. However, the company is expected to continue its regular reporting and management of its investment products, adapting to market conditions as they evolve.
Read Next
Rockport Wealth LLC Reports $571 Million in Holdings
BXM Wealth LLC Reports $186.79 Million in Holdings
Similarweb issues supplemental disclosure ahead of meeting
Town Capital LLC Reports $156M in Latest 13F Filing
Microbot Medical Inc. Releases Annual Report for 2025
Integral Investment Advisors reports $465M portfolio value





